Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2009 3
2010 2
2011 5
2012 6
2013 10
2014 6
2015 7
2016 10
2017 12
2018 19
2019 11
2020 6
2021 6
2022 3
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Compaction Behavior of Co-Amorphous Systems.
Sørensen CM, Rantanen J, Grohganz H. Sørensen CM, et al. Among authors: grohganz h. Pharmaceutics. 2023 Mar 6;15(3):858. doi: 10.3390/pharmaceutics15030858. Pharmaceutics. 2023. PMID: 36986718 Free PMC article.
Influence of Water on Amorphous Lidocaine.
Xu X, Grohganz H, Rades T. Xu X, et al. Among authors: grohganz h. Mol Pharm. 2022 Sep 5;19(9):3199-3205. doi: 10.1021/acs.molpharmaceut.2c00339. Epub 2022 Jul 25. Mol Pharm. 2022. PMID: 35876141
Recent advances in co-amorphous drug formulations.
Dengale SJ, Grohganz H, Rades T, Löbmann K. Dengale SJ, et al. Among authors: grohganz h. Adv Drug Deliv Rev. 2016 May 1;100:116-25. doi: 10.1016/j.addr.2015.12.009. Epub 2016 Jan 21. Adv Drug Deliv Rev. 2016. PMID: 26805787 Review.
Wet granulation of co-amorphous indomethacin systems.
Schütz D, Timmerhaus A, Grohganz H. Schütz D, et al. Among authors: grohganz h. Int J Pharm. 2023 Sep 25;644:123318. doi: 10.1016/j.ijpharm.2023.123318. Epub 2023 Aug 14. Int J Pharm. 2023. PMID: 37586574 Free article.
Emerging trends in the stabilization of amorphous drugs.
Laitinen R, Löbmann K, Strachan CJ, Grohganz H, Rades T. Laitinen R, et al. Among authors: grohganz h. Int J Pharm. 2013 Aug 30;453(1):65-79. doi: 10.1016/j.ijpharm.2012.04.066. Epub 2012 Apr 28. Int J Pharm. 2013. PMID: 22569230 Review.
Preparation of Co-Amorphous Systems by Freeze-Drying.
Wostry M, Plappert H, Grohganz H. Wostry M, et al. Among authors: grohganz h. Pharmaceutics. 2020 Sep 30;12(10):941. doi: 10.3390/pharmaceutics12100941. Pharmaceutics. 2020. PMID: 33008124 Free PMC article.
Dipeptides as co-formers in co-amorphous systems.
Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Rades T, Grohganz H. Wu W, et al. Among authors: grohganz h. Eur J Pharm Biopharm. 2019 Jan;134:68-76. doi: 10.1016/j.ejpb.2018.11.016. Epub 2018 Nov 20. Eur J Pharm Biopharm. 2019. PMID: 30468836
Refining stability and dissolution rate of amorphous drug formulations.
Grohganz H, Priemel PA, Löbmann K, Nielsen LH, Laitinen R, Mullertz A, Van den Mooter G, Rades T. Grohganz H, et al. Expert Opin Drug Deliv. 2014 Jun;11(6):977-89. doi: 10.1517/17425247.2014.911728. Epub 2014 Apr 23. Expert Opin Drug Deliv. 2014. PMID: 24754747 Review.
Aspartame as a co-former in co-amorphous systems.
Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Grohganz H, Rades T. Wu W, et al. Among authors: grohganz h. Int J Pharm. 2018 Oct 5;549(1-2):380-387. doi: 10.1016/j.ijpharm.2018.07.063. Epub 2018 Jul 31. Int J Pharm. 2018. PMID: 30075253
104 results